Flunitrazolam

Flunitrazolam is a benzodiazepine derivative that is structurally related to flunitrazepam and triazolam. It is known for its potent sedative, hypnotic, and anxiolytic properties. Flunitrazolam is not approved for medical use in many countries and is often encountered in the context of recreational drug use.
Chemical Structure and Properties[edit]
Flunitrazolam belongs to the benzodiazepine class of drugs, which are characterized by their core chemical structure: a benzene ring fused to a diazepine ring. The chemical formula of flunitrazolam is C17H12FN5O2, and its molecular weight is 337.31 g/mol. The compound features a fluorine atom at the 2' position of the benzene ring and a triazole ring fused to the diazepine ring.
Pharmacology[edit]
Flunitrazolam acts on the central nervous system by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor. This action results in increased neuronal inhibition, leading to its sedative and anxiolytic effects. The drug has a high affinity for the GABA_A receptor, which contributes to its potency.
Effects and Uses[edit]
The primary effects of flunitrazolam include:
- Sedation
- Hypnosis
- Anxiolysis
- Muscle relaxation
- Anticonvulsant properties
Due to its high potency, flunitrazolam is often used in very small doses. It is not commonly prescribed in clinical settings due to the risk of dependence, tolerance, and abuse.
Legal Status[edit]
Flunitrazolam is classified as a controlled substance in many countries. Its legal status varies, but it is generally subject to strict regulations due to its potential for abuse and lack of approved medical use.
Side Effects[edit]
Common side effects of flunitrazolam include:
In cases of overdose, flunitrazolam can cause severe respiratory depression, coma, and even death.
History[edit]
Flunitrazolam was first synthesized in the late 20th century as part of research into new benzodiazepine derivatives. Despite its potent effects, it has not been widely adopted for medical use.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian